SenGenix, Inc. — Form D/A
SenGenix, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2014-07-07. The offering totals $2.5M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-07-07
- Form: D/A
- Accession: 0001586429-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.0M
- Remaining: $530K
- Investors: 15
- Date of first sale: 2013-08-02
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-202890
Issuer
- Name: SenGenix, Inc.
- CIK: 0001586429
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1738 HILLANDALE ROAD, DURHAM, NC, 27705
- Phone: 919-864-8693
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Ralph S Snyderman | Director | Morrisville, NC |
| Richard S Surwit | Director | Durham, NC |
| Richard S Surwit | Executive Officer | Durham, NC |
| Homme E Hellinga | Director | Durham, NC |
| Homme E Hellinga | Executive Officer | Durham, NC |
| Lawrence S Cohen | Director | Durham, NC |
| Lawrence S Cohen | Executive Officer | Durham, NC |
| Ralph E Snyderman | Director | Durham, NC |
| Sandra E Cummings | Director | Durham, NC |
| Sandra E Cummings | Executive Officer | Durham, NC |
| Homme S Hellinga | Director | Durham, NC |
| Sandra S Cummings | Director | Durham, NC |
| Sandra S Cummings | Executive Officer | Durham, NC |
Other filings by this issuer (4)
More